How to manage aspirin hypersensitivity in a patient with ST-segment elevation myocardial infarction and a drug-eluting stent

References (10)

1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with Figure 2. Schema of our aspirin desensitization protocol. How to? 169 ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018
2. [Crossref] 2. Rossini R, Iorio A, Pozzi R, Bianco M, Musumeci G, Leonardi S, et al. Aspirin desensitization in patients with coronary artery disease: results of the multicenter ADAPTED Registry (aspirin desensitization in patients with coronary artery disease). Circ Cardiovasc Interv 2017
3. e004368. [Crossref] 3. Chopra AM, Díez-Villanueva P, Córdoba-Soriano JG, Lee JKT, Al-Ahmad M, Ferrais VA, et al. Meta-analysis of acetylsalicylic acid desensitization in patients with acute coronary syndrome. Am J Cardiol 2019
4. [Crossref] 4. Jackson M, Callaghan S, Stapleton J, Bolton S, Austin D, Muir DF, et al. Rapid aspirin desensitization is safe and feasible in patients with stable and unstable coronary artery disease: a single-center experience. J Cardiovasc Pharmacol Ther 2019
5. [Crossref] 5. Bianco M, Bernardi A, D’Ascenzo F, Cerrato E, Omedè P, Montefusco A, et al. Efficacy and safety of available protocols for aspirin hypersensitivity for patients undergoing percutaneous coronary intervention: a survey and systematic review. Circ Cardiovasc Interv 2016
6. e002896. [Crossref] 6. Barillà F, Pulcinelli FM, Mangieri E, Torromeo C, Tanzilli G, Dominici T, et al. Clopidogrel plus indobufenin acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention. Platelets 2013
7. [Crossref] 7. White AA, Stevenson DD, Woessner KM, Simon RA. Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc 2013
8. [Crossref] 8. Waldram J, Walters K, Simon R, Woessner K, Waalen J, White A. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: a single-center study. J Allergy Clin Immunol 2018
9. [Crossref] 9. Woessner KM. Aspirin desensitization for cardiovascular disease. Curr Opin Allergy Clin Immunol 2015
10. [Crossref] 10. Córdoba-Soriano JG, Corbí-Pascual M, López-Neyra I, Navarro-Cuartero J, Hidalgo-Olivares V, Barrionuevo-Sánchez MI, et al. Earl